This brand name is authorized in Poland, Singapore, Spain, Turkey.
The drug ANBINEX contains one active pharmaceutical ingredient (API):
1
|
UNII
29Y3UO9LWK - ANTITHROMBIN GAMMA
|
|
Antithrombin III is a small glycoprotein anticoagulant that inactivates several enzymes of the coagulation system and accounts for most of the antithrombin activity in plasma. It is a member of the serpin superfamily. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B01AB02 | Antithrombin III | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AB Heparin group |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ES | Centro de información online de medicamentos de la AEMPS | 59259 |
| PL | Rejestru Produktów Leczniczych | 100108295, 100108303 |
| SG | Health Sciences Authority | 13682P, 13683P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699769980085, 8699769980092 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.